通过WTAP介导的m6A修改TRAIL-DR4抑制MH7A细胞亡
Xiaoya Cui1,2, Fengxia Xu1,3, Xue Pang1,3
1The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
International journal of rheumatic diseases
|January 11, 2025
概括
威尔姆斯瘤1-关联蛋白 (WTAP) 在表观遗传上修改了与TNF相关的诱导亡的联结体死亡受体4 (TRAIL-DR4) mRNA,抑制了类风湿性关节炎 (RA) 细胞中的亡. 这一发现揭示了RA治疗的新型治疗标.
科学领域:
- 表观遗传学和RNA修饰
- 自身免疫性疾病的分子机制
背景情况:
- N6-甲基氨酸 (m6A) 是一种关键的RNA修饰,参与了诸如亡和增殖等生物过程.
- 威尔姆斯瘤1-关联蛋白 (WTAP) 是一个关键的m6A调节器,与细胞增殖和细胞亡有关.
- 在风湿性关节炎 (RA) 中WTAP的作用,其特征是突性增生,仍然在很大程度上未被探索.
研究的目的:
- 调查WTAP介导的m6A修饰TNF相关的诱导亡的联结体死亡受体4 (TRAIL-DR4) 在RA中的作用.
- 阐明WTAP对RA突发性关节细胞中细胞过程的影响.
主要方法:
- 在MH7A细胞中使用等离子体和小干扰RNA过度表达和沉默WTAP.
- 评估基因和蛋白质表达 (WTAP,BCL2,BAX,TRAIL-DR4) 通过免疫光学,RT-qPCR和西方斑点.
- 使用CCK-8,流细胞计和TEM评估细胞活力,细胞循环,细胞亡和增殖.
- 使用MeRIP-qPCR和actinomycin D测试验证TRAIL-DR4 m6A修饰和mRNA稳定性的验证.
主要成果:
- 过度表达WTAP增加了WTAP和BCL2水平,降低了BAX和TRAIL-DR4水平,抑制了细胞亡,并促进了MH7A细胞的细胞活力和增殖.
- 沉默WTAP产生了相反的效果,突出了WTAP的支持生存的作用.
- 发现WTAP促进了TRAIL-DR4 m6A的修饰,降低了TRAIL-DR4 mRNA的稳定性,并随后抑制了亡.
结论:
- 通过WTAP介导的TRAIL-DR4的m6A修饰抑制了RA的突细胞 (MH7A) 中的亡.
- 这种机制为RA提供了一个新的治疗点.
- 这些发现通过m6A变化的镜头来扩大对RA病理生理学的理解.
更多相关视频
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
22.4K
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.1K
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
